Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-23

Clinical Trial Update: Tacrolimus for Malar Edema [Phase 2, Phase 3]

View source ↗

Summary

A mid-stage and pivotal phase trial update for tacrolimus in facial edema, with unspecified status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: University of British Columbia | Conditions: Edema Face | Phase 2, Phase 3 | Status: UNKNOWN